Cleared Traditional

K120744 - XN CHECK BF

K120744 is the FDA 510(k) clearance for XN CHECK BF by Streck. It is a Class 2 Hematology device (product code JPK) cleared through the Traditional 510(k) pathway after a 221-day FDA review.

K120744 · Streck · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2012
Decision
221d
Days
Class 2
Risk

K120744 is an FDA 510(k) clearance for the XN CHECK BF. Classified as Mixture, Hematology Quality Control (product code JPK), Class II - Special Controls.

Submitted by Streck (La Vista, US). The FDA issued a Cleared decision on October 19, 2012 after a review of 221 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Streck devices

Submission Details

510(k) Number K120744 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2012
Decision Date October 19, 2012
Days to Decision 221 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
108d slower than avg
Panel avg: 113d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JPK Mixture, Hematology Quality Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPK Mixture, Hematology Quality Control

All 134
Devices cleared under the same product code (JPK) and FDA review panel - the closest regulatory comparables to K120744.
XN CHECK
K160590 · Streck · Dec 2016
BC-5D Hematology Control
K160606 · R&D Systems, Inc. · Sep 2016
R&D 5D RETIC HEMATOLOGY CONTROL
K130962 · R&D Systems, Inc. · Jul 2013
R&D SYSTEMS BODY FLUID-I HEMATOLOGY CONTROL
K101578 · R&D Systems, Inc. · Apr 2011
COULTER LIN-X LINEARITY CONTROL, MODEL A81196
K100790 · Beckman Coulter, Inc. · Dec 2010
COULTER 4C-EX 300 CELL CONTROL
K100607 · Beckman Coulter, Inc. · Nov 2010